{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:27:32Z","timestamp":1763036852430,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.annder.2014.09.021","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T19:45:21Z","timestamp":1413488721000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u00c9ryth\u00e8me toxique \u00e0 la chimioth\u00e9rapie"],"prefix":"10.1016","volume":"142","author":[{"given":"V.","family":"Sibaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.09.021_bib0005","first-page":"203","article-title":"Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: Part I. Conventional chemotherapeutic drugs","volume":"71","author":"Reyes-Habito","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.09.021_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1529-8019.2011.01432.x","article-title":"Dermatologic manifestations of cytotoxic therapy","volume":"24","author":"Huang","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2014.09.021_bib0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaad.2008.05.018","article-title":"Toxic erythema of chemotherapy: a useful clinical term","volume":"59","author":"Bolognia","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.09.021_bib0020","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2010.04.021","article-title":"Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features","volume":"64","author":"Martorell-Calatayud","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.09.021_bib0025","article-title":"Taxanes-related dermatologic toxicites","author":"Sibaud","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.09.021_bib0030","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1200\/JCO.2011.39.5970","article-title":"Bilateral ear swelling and erythema after chemotherapy: a case of ara-C ears","volume":"30","author":"Anesi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.09.021_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.coc.0000026486.56886.18","article-title":"Cutaneous hand and foot toxicity associated with cancer chemotherapy","volume":"26","author":"Childress","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.annder.2014.09.021_bib0040","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/j.1365-4632.2012.05573.x","article-title":"Localized toxic erythema of chemotherapy during treatment with paclitaxel","volume":"53","author":"Spicknall","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2014.09.021_bib0045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1634\/theoncologist.2011-0033","article-title":"HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome","volume":"16","author":"Sibaud","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.annder.2014.09.021_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/CAD.0000000000000032","article-title":"Life-threatening dermatologic adverse events in oncology","volume":"25","author":"Rosen","year":"2014","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.annder.2014.09.021_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11882-014-0451-7","article-title":"Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell\/basophil mediators","volume":"14","author":"Caiado","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.annder.2014.09.021_bib0060","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00262-012-1273-x","article-title":"Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization","volume":"61","author":"Castells","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.annder.2014.09.021_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10549-014-3001-z","article-title":"Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series","volume":"146","author":"Sibaud","year":"2014","journal-title":"Breast Cancer Res Treat"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814005675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814005675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:02:46Z","timestamp":1758970966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0151963814005675"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.09.021","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9ryth\u00e8me toxique \u00e0 la chimioth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}